No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
NVS240719C105000
- 6.10
- +0.15+2.52%
15min DelayClose Jul 16 15:59 ET
6.30High5.80Low
5.90Open5.95Pre Close41 Volume1.84K Open Interest105.00Strike Price24.42KTurnover71.77%IV0.52%PremiumJul 19, 2024Expiry Date5.53Intrinsic Value100Multiplier2DDays to Expiry0.57Extrinsic Value100Contract SizeAmericanOptions Type0.8039Delta0.0399Gamma17.41Leverage Ratio-0.3641Theta0.0063Rho13.99Eff Leverage0.0267Vega
Intraday
- 5D
- Daily
News
Express News | Novartis AG : TD Cowen Raises Target Price to $125 From $119
Novartis AG Falls Tuesday
This article was automatically generated using Dow Jones technology. Shares of Novartis AG slipped 0.2% to CHF98.90 Tuesday on what proved to be an overall poor trading session for the stock market,
Here's Why Aristotle Capital's International Equity Composite Sold Novartis AG (NVS)
Here's Why Novartis (NVS) Is a Strong Value Stock
MorphoSys Declares Voluntary Delisting From Nasdaq
Express News | Novartis AG : Morgan Stanley Raises Target Price to $114 From $110
Comments
The earnings season is picking up speed, and this mid-July, we're about to get updates from some of the biggest names across various industries. Expect to hear from large banks, healthcare companies, airlines, and some of the tech and telecom giants that we all know.
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
+3
22
Keep an eye on these recently announced M&As: 👀
$Merck & Co(MRK.US$ to acquire EyeBio
$Biogen(BIIB.US$ to acquire HI-Bio™
$Johnson & Johnson(JNJ.US$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals(RPHM.US$
$Novartis AG(NVS.US$ to acquire Mariana Oncology
What companies will be next? 🤔
$Merck & Co(MRK.US$ to acquire EyeBio
$Biogen(BIIB.US$ to acquire HI-Bio™
$Johnson & Johnson(JNJ.US$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals(RPHM.US$
$Novartis AG(NVS.US$ to acquire Mariana Oncology
What companies will be next? 🤔
4
$Esperion Therapeutics(ESPR.US$ Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, have positioned it as defininte acquistion target for larger pharmaceutical companies. Esperion's drugs NEXLIZET and NEXLETOL now have primary prevention labels, NEXLIZET will soon become the drug of choice over a PCSK9 inhibitor says Texas based HeartPlace leading Cardio...
12
Stories you might have missed ![]()
Singapore’s private home sales down nearly half in February; 149 condos sold amid holiday lull
DEVELOPERS in Singapore sold 149 private homes in February, 47 per cent fewer than the 281 units moved in January, data released on Friday (Mar 15) by the Urban Redevelopment Authority showed.
Novartis invests US$256 million to expand Singapore plant
SWISS biopharma giant Novartis has invested US$256 million to expand its biopharm...
Singapore’s private home sales down nearly half in February; 149 condos sold amid holiday lull
DEVELOPERS in Singapore sold 149 private homes in February, 47 per cent fewer than the 281 units moved in January, data released on Friday (Mar 15) by the Urban Redevelopment Authority showed.
Novartis invests US$256 million to expand Singapore plant
SWISS biopharma giant Novartis has invested US$256 million to expand its biopharm...
7
Google's disappointing ad sales growth and AMD's lower revenue guidance have hurt investor sentiment, causing their shares to drop. Byron Allen's offer to acquire Paramount Global is seen as beneficial for shareholders, boosting its share price. Novartis AG's lower Q4 earnings and adjusted mid-term guidance have led to a share price decline.
Read more